Nearly every American’s life has been touched by cancer in some way. The American Cancer Society estimates more than 2 million people will be diagnosed with cancer in 2025, with over 171,000 of those cases in Florida.

In a study published in JAMA Network Open, Dr. Emily L. Podany, Department of Medicine, Washington University in St Louis, Missouri, and colleagues reported on their findings from a multi-institutional cohort study that explored whether Black patients with metastatic breast cancer (mBC) have differences in genomic profiles compared with White patients and also sought to ascertain whether there are inequities in use of targeted treatment between these groups.

Nearly half of patients diagnosed with cancer in 2023 had a history of smoking, and 15% were smokers at the time of their diagnosis, according to new Yale Cancer Center-led research published in in JAMA Oncology.

Scientists at the National Institutes of Health demonstrated a promising step toward using a person’s own immune cells to fight gastrointestinal cancers in a paper in Nature Medicine on Tuesday, the same day the agency was hit with devastating layoffs that left many NIH personnel in tears.

The Community Oncology Alliance (COA) commends Representatives Diana Harshbarger (R-TN-1) and Debbie Wasserman Schultz (D-FL-25) for their leadership in reintroducing the “Seniors’ Access to Critical Medications Act” (H.R. 2484) along with original cosponsors Representatives Carol Miller (R-WV-01), Darren Soto (D-FL-09), Dan Crenshaw (R-TX-02), and Don Davis (D-NC-01).

One of the most common side effects of cancer treatments, including chemotherapy and radiation therapy, is fatigue.

Surgery might not be needed to treat as many as 60% of early-stage breast cancers, a new study says.

The Leukemia & Lymphoma Society (LLS) is raising concerns about recent federal policy changes and executive actions by the Trump administration that they say threaten cancer research and patient care, warning that funding cuts could derail progress.

Due to the destructive nature of COPD on patients’ lungs and well-being, timely diagnosis is key, and integrating spirometry at the time of lung cancer screening could help identify this disease early in an at-risk population